Breaking News Instant updates and real-time market news.

IDXG

Interpace Diagnostics

$1.07

(0.00%)

, LH

LabCorp

$137.67

2.42 (1.79%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57

Interpace finalizes validation of third specimen of ThyGeNEX and ThyraMIR

Interpace Diagnostics Group announced that it has finalized the validation of its third specimen type for its molecular thyroid tests ThyGeNEX and ThyraMIR. Interpace has expanded its services again to now also process specimens prepared in formalin fixed, paraffin-embedded, or FFPEsamples. Prior to this validation, ThyGeNEXT and ThyraMIR were the only marketed molecular products validated with both RNARetain and cytology slides. The Company initiated a partnering arrangement with the Dianon Systems division of LabCorp (LH) and certain regional labs to provide customers with a one-stop service for molecular testing for their indeterminate thyroid nodules. Interpace's validation of cytology slides led to further expansion of its thyroid business in 2018 with former Rosetta Genomics customers when Rosetta filed for Chapter 7 bankruptcy.

IDXG

Interpace Diagnostics

$1.07

(0.00%)

LH

LabCorp

$137.67

2.42 (1.79%)

  • 27

    Jan

  • 07

    Feb

  • 18

    May

IDXG Interpace Diagnostics
$1.07

(0.00%)

06/22/18
06/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sunlands Online (STG) initiated with an Outperform at Credit Suisse. 2. Micron (MU) initiated with a Buy at Benchmark. 3. Interpace Diagnostics (IDXG) initiated with a Buy at Ladenburg. 4. Alteryx (AYX) initiated with an Outperform at Oppenheimer. 5. BioCryst (BCRX) initiated with a Neutral at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/18
LTCO
06/22/18
INITIATION
Target $2.25
LTCO
Buy
Interpace Diagnostics initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter started Interpace Diagnostics Group with a Buy rating and $2.25 price target. The analyst sees 20%-plus growth in 2018 driven by the company's thyroid test.
03/08/18
03/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyler Technologies (TYL) initiated with a Neutral at DA Davidson. 2. Interpace Diagnostics (IDXG) initiated with a Buy at H.C. Wainwright. 3. Crispr Therapeutics (CRSP) initiated with an Outperform at JMP Securities. 4. Quanta Capital Hldgs (QNTA) initiated with an Outperform at Northland. 5. Genocea (GNCA) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/18
HCWC
03/08/18
INITIATION
Target $3
HCWC
Buy
Interpace Diagnostics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Interpace Diagnostics with a Buy rating and $3 price target. The company's diagnostic offerings are differentiated in that PancraGEN has a positive predictive value significantly better than international guidelines for diagnosis of pancreatic malignancy, Selvaraju tells investors in a research note.
LH LabCorp
$137.67

2.42 (1.79%)

01/17/19
01/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Overweight at JPMorgan. 2. Craft Brew (BREW) initiated with a Buy at Maxim while Castle Brands (ROX) was initiated with a Hold. 3. CVS Health (CVS) and LabCorp (LH) were initiated with a Buy at UBS while Walgreens Boots Alliance (WBA) was initiated with a Sell. 4. DTE Energy (DTE) initiated with a Buy at Goldman Sachs while CMS Energy (CMS) was initiated with a Neutral. 5. Zendesk (ZEN) and HubSpot (HUBS) were initiated with an Overweight at Stephens while Adobe (ADBE) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/19
UBSW
01/17/19
INITIATION
Target $169
UBSW
Buy
LabCorp initiated with a Buy at UBS
UBS analyst Kevin Caliendo started LabCorp with a Buy rating and $169 price target. The analyst thinks Diagnostic EBIT stabilization in the second half of 2019 should provide "support to a re-rating" of the company's multiple. Caliendo sees 2%-7% upside to consensus earnings estimates over the long term driven by high-single-digit Covance revenue growth and capital allocation. The recent underperformance of LabCorp creates a positive risk/reward setup into the 2019 guidance call, says the analyst.
01/03/19
01/03/19
DOWNGRADE

Underperform
LabCorp downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded LabCorp to Underperform from Neutral and lowered its price target to $120 from $152. Analyst Derik de Bruin said LabCorp is operating in a price deflationary environment due to headwinds from the Protecting Access to Medicare Act and contract openings for lab contracts. de Bruin views the current environment for labs as unlike prior periods and said recent soft volume trends may be a prelude to deeper structural issues not fully understood by the market
01/03/19
BOFA
01/03/19
DOWNGRADE
BOFA
Underperform
LabCorp downgraded to Underperform from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

ZTS

Zoetis

$98.72

0.95 (0.97%)

17:00
03/19/19
03/19
17:00
03/19/19
17:00
Initiation
Zoetis initiated  »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDM

Piedmont Office Realty

$20.21

-0.27 (-1.32%)

16:59
03/19/19
03/19
16:59
03/19/19
16:59
Hot Stocks
Piedmont Office Realty CEO Miller to retire, Brent smith to succeed »

Piedmont Office Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 15

    May

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Initiation
Teva initiated  »

Teva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FLIC

First Long Island

$22.35

-0.52 (-2.27%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Hot Stocks
First Long Island selects Christopher Becker to succeed Michael Vittorio as CEO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:51
03/19/19
03/19
16:51
03/19/19
16:51
Hot Stocks
Steelcase boosts quarterly dividend 7% to 14.5c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

PRGO

Perrigo

$49.20

0.52 (1.07%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Initiation
Perrigo initiated at SunTrust »

Perrigo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMK

Trustmark

$34.42

-0.7 (-1.99%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Downgrade
Trustmark rating change at Keefe Bruyette »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WIX

Wix.com

$108.92

1.02 (0.95%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Initiation
Wix.com initiated at Guggenheim »

Wix.com initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$19.00

-0.23 (-1.20%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Hot Stocks
Carlyle Group appoints Christopher Finn COO »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Syndicate
Invitation Homes files to sell 43M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Earnings
Steelcase sees FY20 EPS $1.20-$1.35, consensus $1.32 »

Sees FY20 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

16:48
03/19/19
03/19
16:48
03/19/19
16:48
Periodicals
Boeing CEO says understands 'lives depend' on jet safety, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:47
03/19/19
03/19
16:47
03/19/19
16:47
Earnings
Steelcase sees Q1 EPS 16c-20c, consensus 20c »

Sees Q1 revenue $830 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

EOLS

Evolus

, AGN

Allergan

$154.13

3.41 (2.26%)

16:46
03/19/19
03/19
16:46
03/19/19
16:46
Initiation
Evolus, Allergan initiated at SunTrust »

Evolus assumed with a Buy…

EOLS

Evolus

AGN

Allergan

$154.13

3.41 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

NVCR

Novocure

$50.99

-0.11 (-0.22%)

16:45
03/19/19
03/19
16:45
03/19/19
16:45
Initiation
Novocure initiated at SunTrust »

Novocure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated at SunTrust »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated at Guggenheim »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated at SunTrust »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated at SunTrust »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro CEO Rami Elghandour steps down, D. Keith Grossman to succeed »

Nevro announced that D.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

ENDP

Endo

$8.78

0.19 (2.21%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Endo initiated at SunTrust »

Endo initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.